Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis

Diabetic Medicine

Volumn 34, Issue 1, 2017, Pages 27-36

  Butalia, S ^a   Gutierrez, L ^b   Lodha, A ^c   Aitken, E ^d   Zakariasen, A ^c   Donovan, L ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ADVERSE OUTCOME; ARTICLE; CLINICAL OUTCOME; CONGENITAL MALFORMATION; FETUS OUTCOME; GESTATIONAL AGE; GESTATIONAL WEIGHT GAIN; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL HYPERTENSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PROGENY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; ADULT; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; FETUS DEVELOPMENT; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; PRENATAL EXPOSURE;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84973547935     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13150     Document Type: Article

References (33)

1. Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 2007; 41: 1174–1180.
2. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. New Engl J Med 2008; 358: 2003–2015.
3. Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 2015; 350: h102.
4. Zeng YC, Li MJ, Chen Y, Jiang L, Wang SM, Mo XL et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci 2014; 59: 95–101.
5. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med 2009; 151: 264–269.
6. Ainuddin J, Karim N, Hasan AA, Naqvi SA. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes Res Clin Pract 2015; 107: 290–299.
7. Ruholamin S, Eshaghian S, Allame Z. Neonatal outcomes in women with gestational diabetes mellitus treated with metformin in compare with insulin: a randomized clinical trial. J Res Med Sci 2014; 19: 970–975.
8. Refuerzo JS, Gowen R, Pedroza C, Hutchinson M, Blackwell SC, Ramin S. A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. Am J Perinatol 2015; 30: 163–170.
9. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011; 34: 2279–2284.
10. Hague W, Davoren P, Oliver J, Rowan J. Metformin may be useful in gestational diabetes. BMJ 2003; 326: 762.
11. Moore L, Briery C, Clokey D, Martin R, Williford N, Bofill J et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007; 52: 1011–1015.
12. Ijäs H, Vääräsmäki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 2011; 118: 880–885.
13. Hassan J, Karim N, Sheik Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pak J Med Sci 2012; 28: 384–389.
14. Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Prac 2012; 98: 422–429.
15. Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi S, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prevent Med 2013; 4: 327–333.
16. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RPV. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013; 209: 34.
17. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Rönnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013; 15: 246–251.
18. Hickman M, McBride R, Boggess K, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol 2013; 30: 483–490.
19. Ibrahim M, Hamdy A, Shafik A, Taha S, Anwar M, Faris M. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Arch Gynecol Obstet 2014; 289: 959–965.
20. Ijäs H, Vääräsmäki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG 2014; 122: 994–1000.
21. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One 2013; 8: e64585.
22. Li G, Zhao S, Cui S, Li L, Xu Y, Li Y. Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet 2015; 292: 111–120.
23. Goh JEL, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med 2011; 28: 1082–1087.
24. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013; 159: 123–129.
25. Gherman RB, Chauhan S, Ouzounian JG, Lerner H, Gonik B, Goodwin TM. Shoulder dystocia: the unpreventable obstetric emergency with empiric management guidelines. Am J Obstet Gynecol 2006; 195: 657–672.
26. Li N, Liu E, Guo J, Pan L, Li B, Wang P et al. Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS One 2013; 8: e82310.
27. Desai N, Roman A, Rochelson B, Gupta M, Xue X, Chatterjee PK et al. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. Am J Obstet Gynecol 2013; 209: 136.e1–136.e9.
28. Camelo Castillo W, Boggess K, Stürmer T, Brookhart M, Benjamin DK Jr et al. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatrics 2015; 169: 452–458.
29. Carlsen SM, Martinussen MP, Vanky E. Metformin's effect on first-year weight gain: a follow-up study. Pediatrics 2012; 130: 1222–1226.
30. Rø TB, Ludvigsen HV, Carlsen SM, Vanky E. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest 2012; 72: 570–575.
31. Vanky E, Salvesen KÅ, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19: 1734–1740.
32. Salvesen KÅ, Vanky E, Carlsen SM. Metformin treatment in pregnant women with polycystic ovary syndrome—is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound Obstet Gynecol 2007; 29: 433–437.
33. Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogøy K, Kleggetveit O et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010; 95: E448–E455.